Investors

Discover Virbac's Statement on extra-financial performance

SALES 2020
934 M
59%
Companion
animals
41%
Food
producing
animals

(in € million)

Financial public release
& News

2021 third quarter consolidated sales

2021/10/18 - Financial public releases

Excellent revenue growth of 21.2% at the end of September at comparable exchange rates and scope (+16.4% at constant rates and real scope), driven by a very solid third-quarter performance again in all areas

Read more

Virbac and Jectas Innovators sign an agreement

2021/09/29 - Financial public releases

partenariat-jectas-vignette-corpo.pngVirbac and Jectas Innovators are proud to announce the signature of a collaborative agreement for the development of animal health vaccine(s).

Read more

2021 half year results

2021/09/15 - Financial public releases

Significant increase in operating profit from ordinary activities for the first half of 2021 due to the sound market performance and dynamism of our business

Read more

Events
Wednesday January 19

2021 fourth quarter year sales

2022/01/19 

Read moreRead less

Wednesday January 19, 2022 after market close

2021 fourth quarter year sales
(quiet period from January 5, 2022)

Past Events
Monday October 18

2021 third quarter sales

2021/10/18 

Read moreRead less

Monday October 18, 2021 after market close

2021 third quarter sales
(quiet period from October 04, 2021)

Thursday September 16

SFAF meeting - 1st half 2021 financial & strategic information

2021/09/16 

Read moreRead less

Thursday September 16, 2021

SFAF meeting - 1st half 2021 financial & strategic information
 

Wednesday September 15

2021 interim result

2021/09/15 

Read moreRead less

Wednesday September 15, 2021 after market close

2021 interim result
(quiet period from August 18, 2021)